SCHEMBL7983259

SCHEMBL7983259

O=C1CCCCc2ccc(Cl)cc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 8/20 0.59
MAOB P27338 8/20 0.59
F7 P08709 1/20 0.53
PARP1 P09874 1/20 0.53
F3 P13726 1/20 0.53
PARP10 Q53GL7 1/20 0.53
VHL P40337 1/20 0.49
ELOC Q15369 1/20 0.49
ELOB Q15370 1/20 0.49
CYP2A6 P11509 1/20 0.48
PRKCI P41743 1/20 0.47
PBRM1 Q86U86 1/20 0.46
S100A4 P26447 1/20 0.43
MEN1 O00255 1/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
METAP1 P53582 1/20 0.42
TYMS P04818 2/20 0.41
CYP19A1 P11511 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29673182 0.96 MAOA (0.59) MAOAMAOBF7PARP1F3
SCHEMBL1998628 0.96 MAOA (0.59) MAOAMAOBF7PARP1F3
SCHEMBL29506179 0.88 PBRM1 (0.59) MAOAMAOBF7PARP1F3
SCHEMBL1151032 0.88 PBRM1 (0.59) MAOAMAOBF7PARP1F3
SCHEMBL5108894 0.84 MAOA (0.61) MAOAMAOBVHLELOCELOB
SCHEMBL1798900 0.80 MAOA (0.67) MAOAMAOBVHLELOCELOB
SCHEMBL17011806 0.79 MAOA (0.56) MAOAMAOBVHLELOCELOB
SCHEMBL15369023 0.77 MAOA (0.52) MAOAMAOBF7PARP1F3
SCHEMBL16559383 0.77 F7 (0.58) MAOBF7PARP1F3PARP10
SCHEMBL27844098 0.77 MAOA (0.49) MAOAMAOBVHLELOCELOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3218381-B1 SPIRO-THIAZOLONES HOFFMANN LA ROCHE (CH) 2019-01-23 EP disclosed
US-10092551-B2 Spiro-thiazolones HOFFMANN-LAROCHE INC. (US) 2018-10-09 US disclosed
EP-3218381-A1 SPIRO-THIAZOLONES F. Hoffmann-La Roche AG (CH) 2017-09-20 EP disclosed
US-20170246153-A1 SPIRO-THIAZOLONES HOFFMANN-LA ROCHE INC. (US) 2017-08-31 US disclosed
WO-2016075181-A1 SPIRO-THIAZOLONES F. HOFFMANN-LA ROCHE AG (CH) 2016-05-19 WO disclosed
EP-2053095-B1 Ink composition and inkjet recording method using the same FUJIFILM CORP (JP) 2014-03-26 EP disclosed
EP-1741693-B1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE ALCOHOLS NAGOYA IND SCIENCE RES INST (JP) 2011-08-03 EP disclosed
US-20070225528-A1 Process for Producing Optically Active Alcohol NAGOYA INDUSTRIAL SCIENCE RESEARCH CENTER (JP) 2007-09-27 US disclosed
EP-1741693-A1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE ALCOHOLS Nagoya Industrial Science Research Institute (JP) 2007-01-10 EP disclosed
WO-2001064675-A1 CONDENSED THIAZOLAMINES AND THEIR USE AS NEUROPEPTIDE Y5 ANTAGONISTS NOVARTIS AG (CH) 2001-09-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225528-A1 Process for Producing Optically Active Alcohol ADH1C, ADH1A, ADH5 MAOA 2342/4885MAOB 1866/4885F7 1213/4885
US-10092551-B2 Spiro-thiazolones AVPR1A, AVPR2, AVPR1B MAOA 1140/4885MAOB 1797/4885F7 3301/4885
US-20170246153-A1 SPIRO-THIAZOLONES AVPR1A, AVPR2, AVPR1B MAOA 1140/4885MAOB 1797/4885F7 3301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.